Bueno S M, Haupt K, Vijayalakshmi M A
Laboratoire d'Interactions Moléculaires et de Technologie de Séparations, Université de Technologie de Compiègne, France.
Int J Artif Organs. 1995 Jul;18(7):392-8.
We have developed a pseudobiospecific affinity membrane device for selective removal of human IgG from plasma or serum in vitro for clinical apheresis application. The pseudobiospecific affinity ligand L-histidine was immobilized through an ether linkage onto poly(ethylenevinyl alcohol) hollow fiber cartridge. The obtained affinity membranes showed high selectivity for IgG adsorption from untreated human serum. These membranes are able to adsorb IgG1, IgG2, IgG3 if Mops buffer is used, and more selectively IgG1, and IgG3 in Tris-HCl buffer. With respect to the binding capacity, the pseudobiospecific affinity membrane used showed a higher capacity as compared to protein A-membranes described in the literature. Due to the high capacity, specificity and stability of the histidine affinity membranes, in addition to their lower cost, the approach proposed in this paper may offer a useful alternative to protein A based devices in the treatment of immune-related diseases.
我们开发了一种伪生物特异性亲和膜装置,用于在体外从血浆或血清中选择性去除人IgG,以用于临床血液分离应用。伪生物特异性亲和配体L-组氨酸通过醚键固定在聚乙烯醇中空纤维柱上。所得亲和膜对未处理的人血清中的IgG吸附具有高选择性。如果使用Mops缓冲液,这些膜能够吸附IgG1、IgG2、IgG3,而在Tris-HCl缓冲液中更选择性地吸附IgG1和IgG3。关于结合能力,所使用的伪生物特异性亲和膜与文献中描述的蛋白A膜相比具有更高的能力。由于组氨酸亲和膜具有高容量、特异性和稳定性,再加上其成本较低,本文提出的方法可能为基于蛋白A的装置在治疗免疫相关疾病方面提供一种有用的替代方案。